Emergent BioSolutions Q3 Adj. EPS $(0.36) Beats $(0.39) Estimate, Sales $110.000M Miss $123.200M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings BeatsEarnings Misses
Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.39) by 7.69 percent. This is a 133.96 percent decrease over earnings of $1.06 per share
Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.39) by 7.69 percent. This is a 133.96 percent decrease over earnings of $1.06 per share from the same period last year. The company reported quarterly sales of $110.000 million which missed the analyst consensus estimate of $123.200 million by 10.71 percent. This is a 52.40 percent decrease over sales of $231.100 million the same period last year.